Furthermore, regarding epigenetic factors controlling the severity of KRAS-mutant CRC cells, we found that miR-193a-3p expression was effectively downregulated in patients with KRAS-mutant CRC (Figure 5). Here, KRAS is linked to colorectal carcinoma.